Publication date: Apr 19, 2025 The Aedes aegypti mosquito is generally associated with arboviruses that cause yellow fever, dengue, zika and chikungunya. The most efficient way to control their populations ... Read more

Publication date: Apr 19, 2025 Adults older than 65 years are at increased risk for atypical presentations of chikungunya disease, as well as for severe outcomes including death. In this ... Read more

Publication date: Apr 19, 2025 Concepts Keywords Chikungunya Chikungunya Immunogenicity Immunogenicity Safety Lancet Vaccine Particle Virus Safety Vaccine Virus Original Article

Read more

Publication date: Apr 17, 2025 The bacterial endosymbiont Wolbachia has emerged as an effective biocontrol method to reduce arbovirus transmission. Transinfection of wMel Wolbachia from Drosophila melanogaster to Aedes aegypti ... Read more

Publication date: Apr 19, 2025 Chikungunya disease is a growing global public health concern. Vimkunya (previously chikungunya virus virus-like particle vaccine, previously PXVX0317) is a single-dose, pre-filled syringe for intramuscular ... Read more